Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Depression 5Depressive Disorder, Major 3Polycystic Ovary Syndrome 2Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Neoplasms 1Liver Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Glioma 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1ENT Cancer 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Bile Duct Neoplasms 1Behavior, Addictive 1Asthma 1

Interventions

bisaramil 1Varenicline 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Nicotine Chewing Gum 1Moclobemide 1Methods 1Escitalopram 1Early Intervention, Educational 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Behavior, Addictive × Escitalopram × Clear all
NCT03010761 2019-07-24

Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

China Medical University Hospital

Phase 2 Terminated
90 enrolled

Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡